Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer

被引:13
|
作者
Valicenti, RK
Chervoneva, I
Gomella, LG
机构
[1] Thomas Jefferson Univ Hosp, Bodine Ctr Canc Treatment, Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Urol, Philadelphia, PA 19107 USA
关键词
prostate cancer; Gleason score; surgical margins; radiotherapy;
D O I
10.1016/j.ijrobp.2003.07.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate, in Gleason score 7, pT3N0 prostate cancer patients with positive surgical margins, the predictors of progression-free survival and to identify a patient subgroup that would benefit from immediate adjuvant postoperative radiotherapy (ART). Methods and Materials: Between November 1989 and August 1998, 76 men underwent radical prostatectomy and were found to have capsular penetration (pT3N0), surgical Gleason score 7, tumor present at the resection margin, and an undetectable postoperative prostate-specific antigen (PSA) level. All surgical specimens underwent whole-mount serial sectioning to determine the degree of margin positivity (focal vs. extensive). Of the 76 men, 45 underwent early ART (within 6 months with a median dose of 64.8 Gy), and 31 had no immediate treatment. We defined freedom from PSA failure (bNED) as the absence of two consecutive PSA rises >0.2 ng/mL. Results: The median follow-up time was 5.1 years (range, 2-10 years). The ART and non-ART patients were similar with respect to preoperative PSA level, Gleason score (4 + 3 vs. 3 + 4), presence of seminal vesicle invasion, and margin extent. On univariate analysis, margin extent was predictive for improved bNED (5-year bNED rate of 92% vs. 58%, p = 0.010, for men with focal and extensive margins, respectively). Gleason score (4 + 3 vs. 3 + 4), seminal vesicle invasion, and ART were not statistically significant predictors. On multivariate analysis, the preoperative PSA level, margin extent, and ART were independent significant factors. In the group with extensive surgical margins, men receiving ART had a significantly greater 5-year bNED survival rate compared with the non-ART patients (73% vs. 31%, p = 0.004). Conclusion: These data suggest that the amount of microscopic residual tumor significantly affects bNED after radical prostatectomy for Gleason score 7, pT3N0 prostate cancer. In addition, men with pathologic evidence of microscopic local disease appear to benefit from early ART compared with untreated controls. (C) 2004 Elsevier Inc.
引用
收藏
页码:1093 / 1097
页数:5
相关论文
共 50 条
  • [41] The Role of Post-Mastectomy Radiation Therapy in Patients with pT3N0 Breast Cancer and Low Genomic Recurrence Score
    Grzywacz, V. P., II
    Chen, P. Y.
    Jawad, M. S.
    Gustafson, G. S.
    Dilworth, J. T.
    Almahariq, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E4 - E4
  • [42] Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: Differences in outcome between primary Gleason grades 3 and 4
    Lau, WK
    Blute, ML
    Bostwick, DG
    Weaver, AL
    Sebo, TJ
    Zincke, H
    JOURNAL OF UROLOGY, 2001, 166 (05): : 1692 - 1697
  • [43] Prostate cancer patients with overall and highest biopsy Gleason score 3+4=7 have similar outcome
    Verhoef, E.
    Kweldam, C.
    Kummerlin, I.
    Nieboer, D.
    Steyerberg, E.
    Bangma, C.
    Roobol, M.
    van Leenders, A.
    VIRCHOWS ARCHIV, 2017, 471 : S276 - S277
  • [44] Post-operative radiotherapy (P-RXT) after radical prostatectomy (Px) improves progression-free survival (PFS) in pT3N0 prostate cancer (PC)(EORTC 22911)
    Bolla, M
    Van Poppel, H
    Van Cangh, P
    Vekemans, K
    Da Pozzo, L
    Haustermans, K
    Scalliet, P
    Bulens, P
    van Tienhoven, G
    Verbaeys, A
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S126 - S126
  • [45] Meta-Analysis of Long-term Results of Randomized Trials of the Impact of Adjuvant Radiation on Overall, Metastasis-Free, and Biochemical Recurrence-Free Survival for pT3N0 or Margin-Positive Prostate Cancer
    Nguyen, P. L.
    Je, Y.
    Hoffman, K. E.
    Choueiri, T. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S107 - S107
  • [46] IS EVERY PT3A-PROSTATE CANCER (PCA) WITH POSITIVE SURGICAL MARGIN A CANDIDATE FOR ADJUVANT RADIATION (ARTX)? INDIVIDUAL RISK ASSESSMENT BASED ON A PATHOLOGICAL GLEASON SCORE PREDICTIVE MODEL - A MULTICENTRE STUDY
    Karl, Alexander
    Buchner, Alexander
    Stief, Christian
    Tympner, Christiane
    Kirchner, Thomas
    Ganswindt, Ute
    Belka, Claus
    Ganzer, Roman
    Wieland, Wolf
    Eder, Fabian
    Hofstaedter, Ferdinand
    Schilling, David
    Sievert, Karl-Dietrich
    Stenzl, Arnulf
    Scharpf, Marcus
    Fend, Falko
    vom Dorp, Frank
    Hess, Jochen
    Ruebben, Herbert
    Schmid, Kurt Werner
    Porres-Knoblauch, Daniel
    Heidenreich, Axel
    Hangarter, Birgit
    Knuechel-Clarke, Ruth
    Rogenhofer, Michael
    Wullich, Bernd
    Hartmann, Arndt
    Comploj, Evi
    Pycha, Armin
    Hanspeter, Esther
    Pehrke, Dirk
    Sauter, Guido
    Greafen, Markus
    Haese, Alexander
    JOURNAL OF UROLOGY, 2014, 191 (04): : E604 - E604
  • [47] T3N0 GLOTTIC CARCINOMA - DNA S-PHASE AS A PREDICTOR OF THE OUTCOME AFTER RADIOTHERAPY
    TENNVALL, J
    WENNERBERG, J
    WILLEN, R
    ASK, A
    BALDETORP, B
    FERNO, M
    ACTA OTO-LARYNGOLOGICA, 1993, 113 (02) : 220 - 224
  • [48] Langzeitergebnisse der adjuvanten im Vergleich zur Early-Salvage-Bestrahlung beim pT3N0-Prostatakarzinom nach radikaler Prostatektomie Long-term results of adjuvant versus early salvage radiation therapy in pT3N0 prostate cancer after radical prostatectomy
    R. M. Hermann
    H. Christiansen
    Strahlentherapie und Onkologie, 2018, 194 (2) : 181 - 184
  • [49] Topoisomerase II alpha Protein Expression Is Predictor of Outcome in Gleason Score ≥ 7 Prostate Cancer Patients Treated Surgically: An Immunohistochemical Comparison to MIB1
    Cheville, J. C.
    Ida, C. M.
    Karnes, R. J.
    Nair, A.
    Vasmatzis, G.
    LABORATORY INVESTIGATION, 2010, 90 : 184A - 185A
  • [50] Topoisomerase II alpha Protein Expression Is Predictor of Outcome in Gleason Score ≥ 7 Prostate Cancer Patients Treated Surgically: An Immunohistochemical Comparison to MIB1
    Cheville, J. C.
    Ida, C. M.
    Karnes, R. J.
    Nair, A.
    Vasmatzis, G.
    MODERN PATHOLOGY, 2010, 23 : 184A - 185A